Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Proceedings of the National Academy of Sciences of the United States of America|October 13, 2006
Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitorWeisheng Xu, Lang Ngo, Gisela Perez, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 3, 2017
Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumabMilos Dokmanovic, Kathryn E King, Nishant Mohan, et al.
Molecular Cancer Therapeutics|April 14, 2011
Trastuzumab regulates IGFBP-2 and IGFBP-3 to mediate growth inhibition: implications for the development of predictive biomarkers for trastuzumab resistanceMilos Dokmanovic, Yi Shen, Tabetha M Bonacci, et al.
Cancer Research|September 5, 2006
Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cellsYuhong Chen, Milos Dokmanovic, Wilfred D Stein, et al.
Cellular Signalling|July 24, 2012
Small GTPase Rho regulates R-cadherin through Dia1/profilin-1Tabetha M Bonacci, Dianne S Hirsch, Yi Shen, et al.
Oncotarget|July 14, 2016
VPS34 regulates TSC1/TSC2 heterodimer to mediate RheB and mTORC1/S6K1 activation and cellular transformationNishant Mohan, Yi Shen, Milos Dokmanovic, et al.
Cancer Biology & Therapy|May 20, 2014
Trastuzumab-induced recruitment of Csk-homologous kinase (CHK) to ErbB2 receptor is associated with ErbB2-Y1248 phosphorylation and ErbB2 degradation to mediate cell growth inhibitionMilos Dokmanovic, Yun Wu, Yi Shen, et al.
Molecular Cancer Therapeutics|September 19, 2007
Histone deacetylase inhibitors selectively suppress expression of HDAC7Milos Dokmanovic, Gisela Perez, Weisheng Xu, et al.
Cellular Signalling|March 4, 2014
Insulin activation of vacuolar protein sorting 34 mediates localized phosphatidylinositol 3-phosphate production at lamellipodia and activation of mTOR/S6K1Dianne S Hirsch, Yi Shen, Milos Dokmanovic, et al.
Molecular Cancer Therapeutics|December 30, 2015
Ado-Trastuzumab Emtansine Targets Hepatocytes Via Human Epidermal Growth Factor Receptor 2 to Induce HepatotoxicityHaoheng Yan, Yukinori Endo, Yi Shen, et al.
Pageof 3